TCMBANKIN044009 |
Cepharadione A |
NSC650435; NCI60_017554; 5H-Benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline-5,6(7H)-dione, 7-methyl-; cepharadione a; 7-Methyl-5H-[1,3]benzodioxolo[6,5,4-de]benzo[g]quinoline-5,6(7H)-dione; 55610-01-0 |
C18H11NO4 |
305.28 |
CN1C2=CC3=CC=CC=C3C4=C2C(=CC5=C4OCO5)C(=O)C1=O |
TCMBANKIN061676 |
aristolactam F I |
MCULE-4019596365; Piperolactam A; AC1MIW5I; Dibenz(cd,f)indol-4(5H)-one, 1-hydroxy-2-methoxy-; AKOS028108734; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2,4,6,8,12(16),13-HEPTAEN-11-ONE; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2(7),3,5,8,12(16),13-HEPTAEN-11-ONE; NP-013137; 112501-42-5; 1-Hydroxy-2-methoxydibenz(cd,f)indol-4(5H)-one; 1-Hydroxy-2-methoxydibenz[cd,f]indol-4(5H)-one, 9CI; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2(7),3,5,8,12,14-HEPTAEN-11-ONE; 1-Hydroxy-2-methoxy-Dibenz[cd,f]indol-4(5H)-one; 15-hydroxy-14-methoxy-10-azatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(15),2,4,6,8,12(16),13-heptaen-11-one; Aristolactam F1; AristolactamFI; CHEMBL387864; Dibenz[cd,f]indol-4(5H)-one, 1-hydroxy-2-methoxy-; NCGC00385457-01_C16H11NO3_1-Hydroxy-2-methoxydibenzo[cd,f]indol-4(5H)-one; Aristolactam FI; 1-Hydroxy-2-methoxy-Dibenz(cd,f)indol-4(5H)-one; Dibenz[cd,f]indol-4(5H)-one,1-hydroxy-2-methoxy-; ZINC13484719; DTXSID90150083; W1104; 4CN-2034; MolPort-005-945-747; piperolactam a |
C16H11NO3 |
265.26 g/mol |
COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)O |
TCMBANKIN061677 |
Cepharanone B |
Aristololactam bii; 37326-16-2; Dibenz[cd,f]indol-4(5H)-one, 1,2-dimethoxy-; Dibenz(cd,f)indol-4(5H)-one, 1,2-dimethoxy-; cepharanone b; 53948-09-7; AIDS224741; AIDS-224741 |
C17H13NO3 |
279.29 |
COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)OC |